{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:34:02Z","timestamp":1767652442235},"publisher-location":"Boston","reference-count":24,"publisher":"Kluwer Academic Publishers","isbn-type":[{"type":"print","value":"0306477572"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/0-306-48382-3_9","type":"book-chapter","created":{"date-parts":[[2006,2,18]],"date-time":"2006-02-18T20:57:40Z","timestamp":1140296260000},"page":"53-58","source":"Crossref","is-referenced-by-count":3,"title":["Beh\u00e7et\u2019s Disease in Patients of German and Turkish Origin \u2014 A Comparative Study"],"prefix":"10.1007","author":[{"given":"Ina","family":"K\u00f6tter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Vonthein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilhan","family":"G\u00fcnaydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"Kanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Zierhut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"St\u00fcbiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"9_CR1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","volume":"54","author":"D.H. Verity","year":"1999","unstructured":"Verity, D.H., Marr, J.E., Ohno, S., et al., 1999, Beh\u00e7et\u2019s disease, the silk road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54: 213\u2013220.","journal-title":"Tissue Antigens"},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3346\/jkms.2002.17.3.371","volume":"17","author":"H.K. Chang","year":"2002","unstructured":"Chang, H.K., and Cheon, K.S., 2002, The clinical significance of a pathergy reaction in patients with Beh\u00e7et\u2019s disease. J. Kor. Med. Sci. 17: 371\u2013374.","journal-title":"J. Kor. Med. Sci."},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.43.1.74","volume":"43","author":"H. Yazici","year":"1984","unstructured":"Yazici, H., Chamberlain, M.A., Tuzun, Y., et al., 1984, A comparative study of the pathergy reaction among Turkish and British patients with Beh\u00e7et\u2019s disease. Ann. Rheum. Dis. 43: 74\u201375.","journal-title":"Ann. Rheum. Dis."},{"key":"9_CR4","first-page":"488","volume":"150","author":"Ch.C. Zouboulis","year":"1999","unstructured":"Zouboulis, Ch.C., 1999, Epidemiology of Adamantiades-Beh\u00e7et\u2019s disease. Ann. Med. Interne (Paris) 150: 488\u2013498.","journal-title":"Ann. Med. Interne (Paris)"},{"key":"9_CR5","first-page":"159","volume-title":"Beh\u00e7et\u2019s disease","author":"T. O\u2019Neill","year":"1993","unstructured":"O\u2019Neill, T., Rigby, A., McHugh, S., et al., 1993, Regional differences in clinical manifestations of Beh\u00e7et\u2019s disease. In Beh\u00e7et\u2019s disease (B. Wechsler, and P. Godeau, eds.), Excerpta Medica, Amsterdam, pp. 159\u2013163."},{"key":"9_CR6","first-page":"1033","volume":"28","author":"I. Krause","year":"2001","unstructured":"Krause, I., Mader, R., Sulkes, J., et al., 2001, Beh\u00e7et\u2019s disease in Israel: the influence of ethnic origin on disease expression and severity. J. Rheumatol. 28: 1033\u20131036.","journal-title":"J. Rheumatol."},{"key":"9_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1076\/0927-3948(200009)831-KFT141","volume":"8","author":"M. Muhaya","year":"2000","unstructured":"Muhaya, M., Lightman, S., Ikeda, E., et al., 2000, Beh\u00e7et\u2019s disease in Japan and in Great Britain: a comparative study. Ocul. Immunol, Inflamm. 8: 141\u2013148.","journal-title":"Ocul. Immunol, Inflamm."},{"key":"9_CR8","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s disease, 1990, Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 335: 1078\u20131080.","journal-title":"Lancet"},{"key":"9_CR9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3349\/ymj.1997.38.6.411","volume":"38","author":"Ch.C. Zouboulis","year":"1997","unstructured":"Zouboulis, Ch.C., K\u00f6tter, I., Djawari, D., et al., 1997, Epidemiological features of Adamantiades-Beh\u00e7et\u2019s disease in Germany and in Europe. Yonsei Med. J. 38: 411\u2013422.","journal-title":"Yonsei Med. J."},{"key":"9_CR10","first-page":"820","volume":"15","author":"S. Yurdakul","year":"1998","unstructured":"Yurdakul, S., G\u00fcnaydin, I., T\u00fcz\u00fcn, Y., et al., 1998, The prevalence of Beh\u00e7et\u2019s syndrome in a rural area in northern Turkey. J. Rheumatol. 15: 820\u2013822.","journal-title":"J. Rheumatol."},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-4362.1996.tb03683.x","volume":"35","author":"Y. T\u00fcz\u00fcn","year":"1996","unstructured":"T\u00fcz\u00fcn, Y., Yurdakul, S., Cem Mat, M., et al., 1996, Epidemiology of Beh\u00e7et\u2019s syndrome in Turkey. Int. J. Dermatol. 35: 618\u2013620.","journal-title":"Int. J. Dermatol."},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00002281-200101000-00004","volume":"13","author":"H. Yazici","year":"2001","unstructured":"Yazici, H., Yurdakul, S., and Hamuryudan, V., 2001, Beh\u00e7et\u2019s disease. Curr. Opin. Rheumatol. 13: 18\u201322.","journal-title":"Curr. Opin. Rheumatol."},{"key":"9_CR13","doi-asserted-by":"crossref","unstructured":"Davies, P.G., Fordham, J.N., Kirwan, J.R., et al., The pathergy test and Beh\u00e7et\u2019s syndrome in Britain. Ann. Rheum. Dis. 43: 70\u201373.","DOI":"10.1136\/ard.43.1.70"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3349\/ymj.1997.38.6.423","volume":"38","author":"A. G\u00fcrler","year":"1997","unstructured":"G\u00fcrler, A., Boyvat, A., and T\u00fcrsen, U., 1997, Clinical manifestations of Beh\u00e7et\u2019s disease: an analysis of 2147 patients. Yonsei Med. J. 38: 423\u2013427.","journal-title":"Yonsei Med. J."},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2340\/00015555597779","volume":"59","author":"Y. T\u00fcz\u00fcn","year":"1979","unstructured":"T\u00fcz\u00fcn, Y., Yazici, H., Pazarli, H., et al., 1979, The usefulness of the nonspecific skin hyperreactivity (the pathergy test) in Beh\u00e7et\u2019s disease in Turkey. Acta Derm. Venereol. (Stockholm) 59: 77\u201379.","journal-title":"Acta Derm. Venereol. (Stockholm)"},{"key":"9_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2340\/00015555717576","volume":"71","author":"G. \u00d6zarmagan","year":"1991","unstructured":"\u00d6zarmagan, G., Saylan, T., Azizlerli, G., et al., 1991, Re-evaluation of the pathergy test in Beh\u00e7et\u2019s disease. Acta Derm. Venereol. (Stockholm) 71: 75\u201376.","journal-title":"Acta Derm. Venereol. (Stockholm)"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1034\/j.1399-0039.2001.580304.x","volume":"58","author":"I. K\u00f6tter","year":"2001","unstructured":"K\u00f6tter, I., G\u00fcnaydin, I., St\u00fcbiger, N., et al., 2001, Comparative analysis of the association of HLA-B*51 suballeles with Beh\u00e7et\u2019s disease in patients of German and Turkish origin. Tissue Antigens 58: 166\u2013170.","journal-title":"Tissue Antigens"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1034\/j.1399-0039.2002.590207.x","volume":"59","author":"N. Mizuki","year":"2002","unstructured":"Mizuki, N., Ota, M., Katsuyama, Y., et al., 2002, Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and-B*5108 with Beh\u00e7et\u2019s disease in Greek patients. Tissue Antigens 59: 118\u2013121.","journal-title":"Tissue Antigens"},{"key":"9_CR19","first-page":"2","volume":"43","author":"E. Ghayad","year":"1995","unstructured":"Ghayad, E., and Tohme, A., 1995, Beh\u00e7et\u2019s disease in Lebanon: report of 100 cases. J. Med. Liban. 43: 2\u20137.","journal-title":"J. Med. Liban."},{"key":"9_CR20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1399-0039.1981.tb00687.x","volume":"17","author":"A.U. M\u00fcft\u00fcoglu","year":"1981","unstructured":"M\u00fcft\u00fcoglu, A.U., Yazici, H., Yurdakul, S., et al., 1981, Beh\u00e7et\u2019s disease: lack of correlation of clinical manifestations with HLA antigens. Tissue Antigens 17: 226\u2013230.","journal-title":"Tissue Antigens"},{"key":"9_CR21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/ard.42.5.602","volume":"42","author":"H. Yazici","year":"1983","unstructured":"Yazici, H., Chamberlain, M.A., Schreuder, G.M., et al., 1983, HLA B5 and Beh\u00e7et\u2019s disease. Ann. Rheum. Dis. 42: 602\u2013603.","journal-title":"Ann. Rheum. Dis."},{"key":"9_CR22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/40.6.668","volume":"40","author":"A. G\u00fcl","year":"2001","unstructured":"G\u00fcl, A., Uyar, F.A., Inanc, M., et al., 2001, Lack of association of HLA-B*51 with a severe disease course in Beh\u00e7et\u2019s disease. Rheumatology (Oxford) 40: 668\u2013672.","journal-title":"Rheumatology (Oxford)"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000247169","volume":"188","author":"G. Azizleri","year":"1994","unstructured":"Azizleri, G., Aksungur, V.L., Sarica, R., et al., 1994, The association of HLA-B5 antigen with specific manifestations of Beh\u00e7et\u2019s disease. Dermatology 188: 293\u2013295.","journal-title":"Dermatology"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/rheumatology\/40.2.121","volume":"40","author":"H. Yazici","year":"2001","unstructured":"Yazici, H., Biyikili, S., van der Linden, S.M., et al., 2001, The \u201czero patient\u201d design to compare the prevalences of rare diseases. Rheumatology (Oxford) 40: 121\u2013122.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Advances in Experimental Medicine and Biology","Adamantiades-Beh\u00e7et\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/0-306-48382-3_9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:48:20Z","timestamp":1706921300000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/0-306-48382-3_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["0306477572"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/0-306-48382-3_9","relation":{},"subject":[]}}